Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis

Tissue Antigens

Volumn 82, Issue 3, 2013, Pages 192-196

  Cherciu, M ^a   Popa, L O ^b   Bojinca, M ^a   Dutescu, M I ^c   Bojinca, V ^a   Bara, C ^a   Popa, O M ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Grigore Antipa National Museum of Natural History   (Romania)

^c National Institute of Hematology and Blood Transfusion   (Romania)

Author keywords

Ankylosing spondylitis; ERAP1; HLA B27; Spondyloarthritis

Indexed keywords

AMINOPEPTIDASE; CYTOKINE RECEPTOR; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ERAP1 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; ROMANIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLARTHRITIS;

ANKYLOSING SPONDYLITIS; ERAP1; HLA-B27; SPONDYLOARTHRITIS;

ADULT; AMINOPEPTIDASES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 84882579124     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12158     Document Type: Article

References (35)

1. Maksymowych WP, Rahman P, Reeve JP, Gladman DD, Peddle L, Inman RD. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum 2006: 54: 974-85.
2. Sims AM, Wordsworth BP, Brown MA. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 2004: 4: 13-20.
3. Burton PR, Clayton DG, Cardon LR et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007: 39: 1329-37.
4. Reveille JD, Sims AM, Danoy P et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010: 42: 123-7.
5. Szczypiorska M, Sanchez A, Bartolome N et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology 2011: 50: 1969-75.
6. Pazar B, Safrany E, Gergely P, Szanto S, Szekanecz Z, Poor G. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 2010: 37: 379-84.
7. Choi CB, Kim TH, Jun JB et al. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann Rheum Dis 2010: 69: 582-4.
8. Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009: 60: 1317-23.
9. Harvey D, Pointon JJ, Evans DM et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009: 18: 4204-12.
10. Chen R, Yao L, Meng T, Xu W. The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8, 530 cases and 12, 449 controls. Rheumatol Int 2012: 32: 909-14.
11. Zvyagin IV, Dorodnykh VY, Mamedov IZ et al. Association of ERAP1 allelic variants with risk of ankylosing spondylitis. Acta Naturae 2010: 2: 72-7.
12. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008: 58: 1020-5.
13. Karaderi T, Harvey D, Farrar C et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology 2009: 48: 386-9.
14. Kanaseki T, Blanchard N, Hammer GE, Gonzalez F, Shastri N. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006: 25: 795-806.
15. Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006: 7: 103-12.
16. Cui X, Rouhani FN, Hawari F, Levine SJ. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003: 171: 6814-9.
17. Cui X, Rouhani FN, Hawari F, Levine SJ. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 2003: 278: 28677-85.
18. Cui X, Hawari F, Alsaaty S et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002: 110: 515-26.
19. Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D. Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci 2012: 13: 8338-52.
20. Evnouchidou I, Kamal RP, Seregin SS et al. Cutting edge: coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 2011: 186: 1909-13.
21. Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis 2012: 71: 589-95.
22. Keidel S, Chen L, Pointon J, Wordsworth P. ERAP1 and ankylosing spondylitis. Curr Opin Immunol 2013: 25: 97-102.
23. Evans DM, Spencer CC, Pointon JJ et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011: 43: 761-7.
24. Wang CM, Ho HH, Chang SW et al. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther 2012: 14: R125.
25. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984: 27: 361-8.
26. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006: 54: 2665-73.
27. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991: 34: 1218-27.
28. Popa OM, Bojinca M, Bojinca V et al. Distribution of HLA-B27 in Romanian spondyloarthritides patients. Int J Immunogenet 2010: 37: 513-6.
29. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005: 76: 887-93.
30. Purcell S. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007: 81: 559-75.
31. Brown MA. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 2008: 47: 132-7.
32. Brionez TF, Reveille JD. The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis. Curr Opin Rheumatol 2008: 20: 384-91.
33. Kadi A, Izac B, Said-Nahal R et al. Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis 2012: 15: 15.
34. Jadon D, Tillett W, Wallis D et al. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology 2012: 23: 23.
35. Lee YH, Choi SJ, Ji JD, Song GG. Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 2011: 60: 999-1003.